These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 15182263)

  • 1. Management of malignant pleural effusions.
    Lee YC; Light RW
    Respirology; 2004 Jun; 9(2):148-56. PubMed ID: 15182263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant pleural effusion, current and evolving approaches for its diagnosis and management.
    Neragi-Miandoab S
    Lung Cancer; 2006 Oct; 54(1):1-9. PubMed ID: 16893591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.
    Debeljak A; Kecelj P; Triller N; Letonja S; Kern I; Debevec L; Rozman A
    J BUON; 2006; 11(4):463-7. PubMed ID: 17309178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
    Stefani A; Natali P; Casali C; Morandi U
    Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of malignant pleural effusion by pleurodesis with talc].
    Filippetti M; Crucitti G; Vanni B; Della Giulia M; Foggi P; Del Monte G
    Chir Ital; 2000; 52(5):541-7. PubMed ID: 11190547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
    Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
    Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleurodesis for malignant pleural effusions: current controversies and variations in practices.
    West SD; Davies RJ; Lee YC
    Curr Opin Pulm Med; 2004 Jul; 10(4):305-10. PubMed ID: 15220757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current treatment strategy in malignant pleural effusion].
    Türler A; Walter M; Schmitz-Rixen T
    Wien Klin Wochenschr; 1996; 108(9):255-61. PubMed ID: 8686317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in pleurodesis.
    Rodriguez-Panadero F
    Curr Opin Pulm Med; 1997 Jul; 3(4):319-25. PubMed ID: 9262121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thoracentesis and pleurodesis in the treatment of pleural effusion. Personal experience].
    Pisello F; Geraci G; Sciumè C; Li Volsi F; Platia L; Facella T; Romeo M; Modica G
    G Chir; 2008; 29(6-7):299-304. PubMed ID: 18544270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Talc--a standard drug in the treatment of malignant pleural effusion].
    Bednár M; Bezdícek P
    Cas Lek Cesk; 1999 Jan; 138(3):82-4. PubMed ID: 10376391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
    Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
    J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of malignant pleural effusions and talc pleurodesis.
    Antony VB
    Pneumologie; 1999 Oct; 53(10):493-8. PubMed ID: 10596552
    [No Abstract]   [Full Text] [Related]  

  • 14. [VATS in malignant pleural effusions].
    Cui Y; Wang J; Liu T
    Zhonghua Wai Ke Za Zhi; 1997 Nov; 35(11):675-6. PubMed ID: 10678010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of malignant pleural effusion.
    Taubert J
    Nurs Clin North Am; 2001 Dec; 36(4):665-83, vi. PubMed ID: 11726346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis.
    Fysh ET; Thomas R; Read CA; Kwan BC; Yap E; Horwood FC; Lee P; Piccolo F; Shrestha R; Garske LA; Lam DC; Rosenstengel A; Bint M; Murray K; Smith NA; Lee YC
    BMJ Open; 2014 Nov; 4(11):e006757. PubMed ID: 25377015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Video-assisted management of malignant pleural effusion in breast carcinoma.
    Gasparri R; Leo F; Veronesi G; De Pas T; Colleoni M; Maisonneuve P; Pelosi G; Galimberti V; Spaggiari L
    Cancer; 2006 Jan; 106(2):271-6. PubMed ID: 16342163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
    Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
    Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of recurrent malignant pleural effusion with chemical pleurodesis.
    Kilic D; Akay H; Kavukçu S; Kutlay H; Cangir AK; Enön S; Kadilar C
    Surg Today; 2005; 35(8):634-8. PubMed ID: 16034542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant pleural effusion and talc pleurodesis. Experimental model regarding early kinetics of talc particle dissemination in the chest after experimental talc pleurodesis.
    Stamatelopoulos A; Koullias G; Arnaouti M; Donta I; Perrea D; Dosios T
    J BUON; 2009; 14(3):419-23. PubMed ID: 19810132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.